Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| L-Theanine | Phenibut | |
|---|---|---|
| Category | Amino Acids | Nootropics |
| Standard Dose | 100-200mg daily (or as needed for acute anxiety/focus) | 250-750 mg as needed, maximum 1-2 times per week (for educational context — carries significant dependence risk) |
| Timing | Flexible: morning for calm focus (stack with caffeine), before stressful events, or evening for relaxation/sleep onset. Onset: 30-60 minutes oral, 15-20 min sublingual. | On an empty stomach (food significantly reduces absorption). Onset 2-4 hours. Effects last 4-8 hours with residual effects up to 24 hours. Half-life approximately 5.3 hours. |
| Cycle Duration | ongoing or as needed | STRICTLY intermittent use only — maximum 1-2 times per week. NEVER use daily for more than 1 week. Tolerance develops within days, leading to dose escalation and dependence. |
| Evidence Level | strong_human | moderate_human |
L-Theanine (gamma-glutamylethylamide) crosses the blood-brain barrier via the large neutral amino acid transporter. It increases alpha brain wave activity (8-13 Hz, associated with relaxed alertness), enhances GABA, serotonin, and dopamine levels in the brain, and antagonizes glutamate excitotoxicity by blocking glutamate binding at AMPA, kainate, and NMDA receptors. It also increases BDNF and NGF expression, supporting neuroplasticity. The combination of glutamate antagonism and GABA/serotonin enhancement produces anxiolysis without sedation — a 'calm focus' state.
100-200mg daily (or as needed for acute anxiety/focus)
Flexible: morning for calm focus (stack with caffeine), before stressful events, or evening for relaxation/sleep onset. Onset: 30-60 minutes oral, 15-20 min sublingual.
ongoing or as needed
Beta-phenyl derivative of GABA that crosses the blood-brain barrier (unlike GABA itself) due to the addition of a phenyl ring. Acts as a full agonist at GABA-B receptors with 30-68x lower affinity than baclofen, requiring correspondingly higher doses. Also binds to and blocks alpha-2-delta subunit-containing voltage-dependent calcium channels (VDCCs), making it a gabapentinoid similar to gabapentin and pregabalin. At low concentrations, mildly increases dopamine levels in the brain, providing stimulatory and nootropic effects alongside anxiolysis. Weak agonist activity at GABA-A receptors at higher doses.
250-750 mg as needed, maximum 1-2 times per week (for educational context — carries significant dependence risk)
On an empty stomach (food significantly reduces absorption). Onset 2-4 hours. Effects last 4-8 hours with residual effects up to 24 hours. Half-life approximately 5.3 hours.
STRICTLY intermittent use only — maximum 1-2 times per week. NEVER use daily for more than 1 week. Tolerance develops within days, leading to dose escalation and dependence.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →